Archive for July 2019
FDA issues warning to Wakefield-based Curaleaf over CBD products
Curaleaf is facing an admonition from the FDA over its CBD products, a week after receiving a warning from Massachusetts cannabis regulators over a change in ownership without the state’s approval. Read More
Read MoreUnited Technologies says Raytheon merger will return $20B to shareholders by 2023
The CEO of United Technologies Corp. touted what he says are the financial advantages of a planned merger with Waltham-based Raytheon Co. in upcoming years, appearing to address complaints about the deal in recent weeks from high-profile investors. Read More
Read MoreBiogen downplays ‘premature’ talk of competition for SMA drug Spinraza
During an earnings call Tuesday morning, executives at Biogen Inc. brushed off investor concerns about competitors closing in on its key drugs. Read More
Read MoreState cannabis office closed due to building water leak
The Cannabis Control Commission has 297 applications in different stages of renew and medical marijuana patient forms to process. But for at least two days, that work will have to happen remotely. Read More
Read MoreFive things you need to know today, tax breaks and broken promises
Good morning! Here are the five most important things you need to know to get your workday started today, a bit of sports-business news and some odds and ends that make your water-cooler talk more interesting. Read More
Read MoreDynatrace raises IPO price to $408M
Waltham-based Dynatrace Holdings LLC is boosting the price of its IPO in what could become the first Massachusetts-based technology company’s initial public offering this year. Read More
Read MoreJudge questions Ropes & Gray’s role in college bribery case
A federal judge in Boston on Monday warned a defendant in the college bribery scandal that continuing to employ Ropes & Gray LLP as his counsel could ultimately hurt his defense, but he maintained he wanted to stick with the firm regardless of potential conflicts of interest. Read More
Read MoreJoyn Bio signs $75M microbe licensing deal that could help Bayer
Through the partnership, Joyn Bio will get access to a catalog of thousands of different microbe strains, as well as NewLeaf’s manufacturing capabilities. The deal could significantly benefit Bayer AG, which owns 50 percent of Joyn Bio and is currently battling multiple lawsuits related to a chemical pesticide sold by its recently acquired subsidiary, Monsanto…
Read MoreUMass tuition freeze dies in budget talks
While both the House and the Senate funded UMass at $558 million, the Senate included a prohibition on raising tuition or fees for in-state undergraduates. That tuition freeze, which UMass officials said would force cuts across its campuses, was scrapped during negotiations and not included in the final budget sent to Gov. Charlie Baker’s desk…
Read MoreViewership down double digits for Sox, Yankees
At the local level, 13 Major League Baseball clubs have seen an increase in their cable TV ratings for games so far this year while 15 teams have seen a decline. Read More
Read More